                </a></li></ul></div><p><strong>Figure 1.  <span>Increased pSmad2/3 expression and activation of TGFβ signaling in LRP<sup>−</sup> mouse aorta.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>Longitudinal sections of abdominal aorta from SM22Cre<sup>+</sup>;LRP<sup>flox/flox</sup>;LDLR<sup>−/−</sup> (LRP<sup>−</sup>) and LRP<sup>flox/flox</sup>;LDLR<sup>−/−</sup> (LRP<sup>+</sup>) mice were stained with anti-TSP1, anti-TGFβ1, anti-pSmad2/3 and anti-pSmad1 antibodies. Reduced LRP1 expression results in greatly enhanced expression of pSmad2/3 and its target gene, TSP1. By contrast, TGFβ1 levels were slightly reduced, pSmad1 levels did not change. Bar in a indicates 20 µm.</p>
